A Public Service Announcement from Shaw American
Since opening its doors in 2007, the Cardiovascular Innovation Institute (CII), a joint initiative between the University of Louisville and Jewish Hospital and St. Mary’s HealthCare has focused on the discovery, development and implementation of innovative treatments for cardiovascular disease.
Their main goal is to foster a highly collaborative, integrated, multi-disciplinary world-class enterprise encompassing basic, translational, and clinical and population research in cardiovascular disease affecting individuals from pre-natal life to death. This is also the goal of the National Institutes of Health and has been identified as the most important area of medical research for the next decade.
On May 2nd, 2012 there will be a news segment on WHAS11 to feature a story of a local woman survivor and the work of CII investigator Dr. Amanda LeBanc in women’s heart health.
Tune your DVRs to the 6 PM newscast on WHAS11 TV on Wednesday, May 2. That’s when the station will air the story of Diana Mikel, a Louisville, KY stroke survivor, who after suffering a stroke and getting a valve replaced last year is now training for a triathalon. The piece then goes into the research being done here at the Cardiovascular Innovation Institute in regenerative medicine, and specifically Dr. Amanda LeBlanc’s studies of heart disease in women.
Michael Neumann
Cardiovascular Innovation InstituteCardiovascular disease continues to be the number-one killer of Americans. CII’s researchers and staff are dedicated to reversing this statistic. They invite you to join our fight by learning more about their work, taking a tour of their labs and making a financial contribution that will save lives.